设为首页加入收藏
图片
栏目导航
 
 
点评搜索
 
 
点评详情
发布于:2018-11-6 11:33:25  访问:43 次 回复:0 篇
版主管理 | 推荐 | 删除 | 删除并扣分
In filament cross-linker Lplastin confers resistance to TNF-alpha in MCF-7 breast
Zielonka TM, Demkow U, Filewska M, Bialas-Chromiec B, Zycinska K, Radzikowska E, Puromycin (Dihydrochloride) cost Korzeniewska M, Wardyn KA, Kus J, Skopinska-Rozewska E: Angiogenic activity of sera from silicosis and pulmonary Langerhans cell histiocytosis individuals in relation to lung function tests. 28. Chen J, Ye L, Zhang L, Jiang WG: The molecular effect of pigment epithelium-derived factor, PEDF, on lung cancer cells along with the clinical significance. Int J Oncol 2009, 35(1):159-66. 29. Rodr uez-Pi iro AM, Blanco-Prieto S, S chez-Otero N, Rodr uezBerrocal FJ, de la Cadena MP: Around the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion. J Proteomics 2010, 73(8):1511-22. 30. Broadhead ML, Dass CR, Choong PF: Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy. Trends Mol Med 2009, 15(ten):461-7. 31. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS: Pigment epithelium-derived issue in idiopathic pulmonary fibrosis: a part in aberrant angiogenesis. Am J Respir Crit Care Med 2004, 170(3):242-51. 32. Szlubowski A, Soja J, Grzanka P, Tomaszewska R, Papla B, Kuzdzal J, Cmiel A, Sladek K: TGF-beta1 in bronchoalveolar lavage fluid in diffuse parenchymal lung ailments and high-resolution computed tomography score. Pol Arch Med Wewn 2010, 120(7-8):270-5. 33. Zielonka TM, Demkow U, Puscinska E, Golian-Geremek A, Filewska M, Zycinska K, Bialas-Chromiec B, Wardyn KA, Skopiska-R ewska E: TNFalpha and INFgamma inducing capacity of sera from individuals with interstitial lung disease in relation to its angiogenesis activity. J Physiol Pharmacol 2007, 58(Suppl five Pt two):767-80. 34. Senechal B, Elain G, Jeziorski E, Grondin V, Patey-Mariaud de Serre N, Jaubert F, Beldjord K, Lellouch A, Glorion C, Zerah M, Mary P, Barkaoui M, Emile PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28724915 JF, Boccon-Gibod L, Josset P, Debr?M, Fischer A, Donadieu J, Geissmann F: Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 2007, four(eight):e253. 35. Zielonka TM, Demkow U, Filewska M, Bialas-Chromiec B, Zycinska K, Radzikowska E, Korzeniewska M, Wardyn KA, Kus J, Skopinska-Rozewska E: Angiogenic activity of sera from silicosis and pulmonary Langerhans cell histiocytosis patients in relation to lung function tests. J Physiol Pharmacol 2008, 59(Suppl 6):781-9. 36. Rescher U, Gerke V: Annexins nique membrane binding proteins with diverse functions. J Cell Sci 2004, 117(Pt 13):2631-9. 37. Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S: Annexin A3 is usually a prospective angiogenic mediator. Biochem Biophys Res Commun 2005, 337(four):1283-7. 38. Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, Li F, Chen YH, Yi H, Yao HX, Chen ZC: Quantitative proteome evaluation reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 2009, 217(1):54-64. 39. Wood AM, Stockley RA: Alpha one antitrypsin deficiency: from gene to therapy. Respiration 2007, 74(five):481-92. 40. Brown RE: Oxidative stress, p53expression, and cytogenetic abnormalities in Langerhans cell histiocytosis. Med Pediatr Oncol 2002, 38(1):70-1. 41.
共0篇回复 每页10篇 页次:1/1
共0篇回复 每页10篇 页次:1/1
我要回复
回复内容
验 证 码
看不清?更换一张
匿名发表 
图片
脚注信息
版权所有 Copyright(C)2009-2010 杭州市某某茶叶贸易有限公司